NEA's Even Bigger Thinking

The venture capital firm has raised $2.5 billion to invest in life sciences and emerging markets. Can it wisely spend that much money?

These aren't exactly the best of times for venture capital. In the past few years investors have pumped $20 billion into new companies only to get about an equal amount back when they take the companies public or sell them.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.